MacroGenics, Inc. (MGNX) - NASDAQ
From other sites
Company Description
MacroGenics, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. It is focused on three therapeutic areas: Oncology, Autoimmune Disorders and... More
Sector: Healthcare
Industry: Biotechnology
Country: United States